QQ客服 官方微博 反馈留言

	Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery
	Zhao, Yinbo[1,4]; Lin, Dayong[2,3]; Wu, Fengbo[1]; Guo, Li[4]; He, Gu[1]; Ouyang, Liang[1]; Song, Xiangrong[1]; Huang, Wei[5]; Li, Xiang[1]
	2014
卷号	15期号:10页码:17565-17576
URL标识	查看原文
WOS记录号	WOS:000348039400011
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4291317
专题	成都中医药大学
作者单位	1.[1]Sichuan Univ, West China Hosp, Dept Pharm & Urol, State Key Lab Biotherapy, Chengdu 610041, Peoples R China 2.[2]Sichuan Acad Med Sci, Dept Anesthesiol, Chengdu 610072, Peoples R China 3.[3]Sichuan Prov People s Hosp, Chengdu 610072, Peoples R China 4.[4]Sichuan Univ, West China Sch Pharm, Chengdu 610041, Peoples R China 5.[5]Chengdu Univ Tradit Chinese Med, State Key Lab Breeding Base Systemat Res Dev & Ut, Chengdu 611137, Peoples R China
推荐引用方式 GB/T 7714	Zhao, Yinbo[1,4],Lin, Dayong[2,3],Wu, Fengbo[1],et al. Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery[J],2014,15(10):17565-17576.
APA	Zhao, Yinbo[1,4].,Lin, Dayong[2,3].,Wu, Fengbo[1].,Guo, Li[4].,He, Gu[1].,...&Li, Xiang[1].(2014).Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery.,15(10),17565-17576.
MLA	Zhao, Yinbo[1,4],et al."Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery".15.10(2014):17565-17576.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。